Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

FDA approves Alinia tablets for adults

July 27, 2004

Isis scientists describe new anti-HCV agents targeting IRES

July 27, 2004

NEC discovers new peptide-vaccine candidates for hepatitis C

July 26, 2004

Roche seeks U.S. and E.U. approval for Pegasys in hepatitis B

July 23, 2004

SBIR grant for IBD research at Adenosine Therapeutics and U. of Virginia

July 23, 2004

Phase II results for INKP-102

July 21, 2004

Zelnorm recommended for approval for chronic constipation with restrictions

July 19, 2004

GlaxoSmithKline and Biota hepatitis C collaboration to conclude

July 14, 2004

Selective angiotensin AT2 receptor agonists described by Vicore Pharma

July 13, 2004

European approval for Pariet for Zollinger-Ellison syndrome

July 12, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...